Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation-Reference-Cited by-同舟云学术

Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation

Published:2013-08-23 Issue:8 Volume:8 Page:e71596
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bedel Aurélie,Pasquet Jean- Max,Lippert Éric,Taillepierre Miguel,Lagarde Valérie,Dabernat Sandrine,Dubus Pierre,Charaf Lucie,Beliveau François,de Verneuil Hubert,Richard Emmanuel,Mahon François-Xavier,Moreau-Gaudry François

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Pushing the limits of targeted therapy in chronic myeloid leukaemia;T O'Hare;Nat Rev Cancer,2012

2. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;BJ Druker;N Engl J Med,2006

3. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial;FX Mahon;Lancet Oncol,2010

4. Frequency of major molecular responses to imatinib or interferon alpha plus cytarabine in newly diagnosed chronic myeloid leukemia. International Randomised Study of Interferon versus STI571 (IRIS) Study Group;TP Hughes;N Engl J Med,2003

5. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro;SM Graham;Blood,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restricting epigenetic activity promotes the reprogramming of transformed cells to pluripotency in a line-specific manner;Cell Death Discovery;2023-07-14

2. Inhibition of BCR::ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells;2023-06-05

3. Modulating the epigenetic state promotes the reprogramming of transformed cells to pluripotency in a line-specific manner;2022-12-02

4. Evidence of Increased Hemangioblastic and Early Hematopoietic Potential in Chronic Myeloid Leukemia (CML)-derived Induced Pluripotent Stem Cells (iPSC);StemJournal;2022-03-22

5. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies;Cells;2021-11-19